-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, LlSI5Q6B3R3BecM527rfmDzHYOCTmkC00HL1mvXKFBnlreg+EQ3a0EPHLq72lPN4 edByBoPOF0lSeQK6L4XWgQ== 0000950135-07-004049.txt : 20070629 0000950135-07-004049.hdr.sgml : 20070629 20070629155237 ACCESSION NUMBER: 0000950135-07-004049 CONFORMED SUBMISSION TYPE: 15-12G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070629 DATE AS OF CHANGE: 20070629 EFFECTIVENESS DATE: 20070629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIOSITE INC CENTRAL INDEX KEY: 0000834306 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 330288606 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 15-12G SEC ACT: 1934 Act SEC FILE NUMBER: 000-21873 FILM NUMBER: 07950812 BUSINESS ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6194554808 MAIL ADDRESS: STREET 1: 11030 ROSELLE ST CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: BIOSITE DIAGNOSTICS INC DATE OF NAME CHANGE: 19960710 15-12G 1 b65888bie15v12g.htm BIOSITE INCORPORATED FORM 15 e15v12g
 

 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
Certification and Notice of Termination of Registration under Section 12(g) of the Securities Exchange
Act of 1934 or Suspension of Duty to File Reports Under
Sections 13 and 15(d) of the Securities Exchange Act of 1934.
Commission File Number: 000-21873
Biosite Incorporated
 
(Exact name of registrant as specified in its charter)
9975 Summers Ridge Road
San Diego, California 92121
Telephone: (858) 805-2000
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)
Common Stock, $0.01 par value
 
(Title of each class of securities covered by this Form)
None
 
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)
          Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
                 
Rule 12g-4(a)(1)(i)
  þ       Rule 12h-3(b)(1)(i)   þ
Rule 12g-4(a)(1)(ii)
  o       Rule 12h-3(b)(1)(ii)   o
Rule 12g-4(a)(2)(i)
  o       Rule 12h-3(b)(2)(i)   o
Rule 12g-4(a)(2)(ii)
  o       Rule 12h-3(b)(2)(ii)   o
 
          Rule 15d-6   o
Approximate number of holders of record as of the certification or notice date:   One
 
 

 

 

          Pursuant to the requirements of the Securities Exchange Act of 1934, Biosite Incorporated has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
         
  Biosite Incorporated
 		  
          Dated: June 29, 2007  By: /s/ Jay McNamara    
    Name:  Jay McNamara  
    Title:  Assistant Secretary  
 

 

-----END PRIVACY-ENHANCED MESSAGE-----